Amy McFarling, DDS
Oral & Maxillofacial Surgery · Austin, TXNPI 1255866596
Payments from drug & device makers
Across 42 payments — averaging $125.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$4K
- Stryker$475
- Nexus CMF, LLC$281
- Kerecis Limited$182
- Integra Lifesciences Corporation$149
- Nobel Biocare USA$123
- plus $140 from 3 others
What the payments were for
- Travel & lodging$1,95037%
- Food & beverage$3,30363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 27 | $3,903 |
| Stryker | 5 | $475 |
| Nexus CMF, LLC | 2 | $281 |
| Kerecis Limited | 1 | $182 |
| Integra Lifesciences Corporation | 1 | $149 |
| Nobel Biocare USA | 2 | $123 |
| Acumed LLC | 2 | $75 |
| Straumann USA LLC | 1 | $43 |
| Acera Surgical, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$727
- INTEGRA$446
- McCain Arthroscopy System$271
- CLARIX$240
- Kerecis Omega3 SurgiClose$182
- INTEGRA DERMAL REGENERATION TEMPLATE$149
- PRIMATRIX$149
- NA$137
- SMARTLOCK$117
How this compares
$5,253 in reported general payments places this provider in the 80th percentile of 591 oral & maxillofacial surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 27 | $125 |
| Lidocaine Hcl ViscousLidocaine Hcl | 14 | $97 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Austin
- Harry CasmedesAustin$19K
- James MelvilleHouston$242K
- Arthur FieldsPlano$237K
- Donald GardnerHouston$234K
- Pedro FrancoIrving$91K
- Fayette WilliamsFort Worth$74K
- Craig BuchmannKeller$69K
- John ZunigaDallas$61K
- David AlfiHouston$58K
- Arshad KaleemEl Paso$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.